Biochemical investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 4. Effects on erythrocyte membrane lysis and on red cells aggregation.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001799:Blood Sedimentation; D002449:Cell Aggregation; D002462:Cell Membrane / Q000187:drug effects; D003124:Colorimetry; D004285:Dogs; D004912:Erythrocytes / Q000187:drug effects*; D005260:Female; D006461:Hemolysis / Q000187:drug effects; D006358:Hot Temperature; D008297:Male; D009996:Osmotic Fragility / Q000187:drug effects; D010653:Phenylbutazone / Q000494:pharmacology; D011720:Pyrazoles / Q000494:pharmacology*; D051381:Rats; D013729:Terpenes / Q000494:pharmacology*
D000893:Anti-Inflammatory Agents; D011720:Pyrazoles; D013729:Terpenes; D010653:Phenylbutazone